FDG-PET/CT Imaging in Chimeric Antigen Receptor–Engineered T-Cell Treatment in Patients with B-Cell Lymphoma

IF 3 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

PET Clinics Pub Date : 2024-07-04 DOI:10.1016/j.cpet.2024.05.006

引用次数: 0

B 细胞淋巴瘤患者嵌合抗原受体工程 T 细胞治疗中的 FDG-PET/CT 成像：当前证据。

美国食品药品管理局和欧洲药品管理局最近批准了嵌合抗原受体工程（CAR）T细胞用于治疗多种难治性/复发性B细胞淋巴瘤。本综述旨在说明[18F]-FDG PET/计算机断层扫描（CT）成像在加强对接受 CAR T 细胞治疗的患者的护理方面可发挥的关键作用。为此，本综述解读了显示 [18F]-FDG PET/CT 衍生参数的诊断、预后、预测和治疗价值的证据。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

PET Clinics RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-

CiteScore

5.70

自引率

3.80%

发文量

期刊介绍： As the clinical applications of positron emission tomography (PET) increase, the new PET Clinics brings together the combined expertise of leading authorities in the field to provide you incisive clinical reviews on advances in the use of PET and combined PET/CT. Published quarterly, PET Clinics provides concise, practical guidance on the clinical issues you face every day. It examines PET is effectiveness in cancer diagnosis and staging, as well as exploring PET is usefulness in the areas of dementia, myocardial viability, and other conditions. Full-color images featured throughout. Topics covered include Breast Cancer, Alzheimer is Disease and Dementia, Lymphoma, Lung Cancer, Cardiology, Pediatric Applications, Infection and Inflammation.